Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Pappas

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Journal of Clinical Microbiology|July 10, 2004
Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipientMary E Brandt, Carol A Kauffman, Peter G Pappas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2025
Histopathologic Insights Into Curvularia-Induced Chronic Granulomatous Fungal Sinusitis: A Guide for Surgical PathologistsAshleigh N Riegler, Jessica W Grayson, Jacob W Greenway, et al.
The Journal of Infectious Diseases|June 8, 2004
Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitisPeter G Pappas, Beatriz Bustamante, Eduardo Ticona, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2025
Activity of rezafungin against Candida aurisJeffrey B Locke, David Andes, Shawn Flanagan, et al.
Open Forum Infectious Diseases|April 6, 2026
Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized TrialsLuis Ostrosky-Zeichner, Jalal A Aram, Mark Redell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2010
Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern eraJ Ryan Bariola, Paul Perry, Peter G Pappas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With CandidemiaRachael A Lee, Joanna C Zurko, Bernard C Camins, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitisRobert A Larsen, Peter G Pappas, John Perfect, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis Douglas C Chang, Lauren A Burwell, G Marshall Lyon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases GroupRaoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Journal of Clinical Microbiology|July 10, 2004
Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipientMary E Brandt, Carol A Kauffman, Peter G Pappas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2025
Histopathologic Insights Into Curvularia-Induced Chronic Granulomatous Fungal Sinusitis: A Guide for Surgical PathologistsAshleigh N Riegler, Jessica W Grayson, Jacob W Greenway, et al.
The Journal of Infectious Diseases|June 8, 2004
Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitisPeter G Pappas, Beatriz Bustamante, Eduardo Ticona, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2025
Activity of rezafungin against Candida aurisJeffrey B Locke, David Andes, Shawn Flanagan, et al.
Open Forum Infectious Diseases|April 6, 2026
Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized TrialsLuis Ostrosky-Zeichner, Jalal A Aram, Mark Redell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2010
Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern eraJ Ryan Bariola, Paul Perry, Peter G Pappas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With CandidemiaRachael A Lee, Joanna C Zurko, Bernard C Camins, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitisRobert A Larsen, Peter G Pappas, John Perfect, et al.
Infection Control and Hospital Epidemiology|January 4, 2008
Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis Douglas C Chang, Lauren A Burwell, G Marshall Lyon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases GroupRaoul Herbrecht, Thomas F Patterson, Monica A Slavin, et al.
Pageof 18